Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes.
Original Source
Read the full article at Sciencedaily →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.